Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · KRITI NUTRIENTS LIMITED · 9 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
KRITI NUTRIENTS LIMITED
NSE: KRITINUT · BSE: 533210

KRITI NUTRIENTS LIMITED

StateQ1 FY27 filed
Last close · 8 Oct 2026₹72.21
Market cap₹0.4k cr
TTM P/E · P/B · EV/EBITDA10.8 · 1.58 · 6.3

KRITI NUTRIENTS LIMITED is a listed company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY25–FY26 (all audited; no estimate years)

₹ crore · consolidatedFY25FY26
Revenue734922
EBITDA (ex other income)4843
margin %6.54.7
Owners' profit3734
EPS, as reported (₹)7.386.77
ROE % · ROCE %17.5 · 23.114.8 · 19.4
Debt / equity (x)0.010.03
Cash from operations3264
Capex(5)0
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · KRITI NUTRIENTS LIMITED · 9 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 6 quarters

₹ croreQ4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue200229213224255247
Profit before tax6121212912
Net profit599969
EPS (₹)0.981.891.781.831.271.78
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · KRITI NUTRIENTS LIMITED · 9 October 2026Page 3 of 3

Exhibit 3: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportance1-day %5-day %
28 Sept 2026 · Trading window closed from Oct 1 until Q2 FY26 results declaredcomplianceminimal——
15 Sept 2026 · Clarification on auditor review report format for Q1 FY27 resultscomplianceminimal——
9 Sept 2026 · Minutes of 30th AGM of Kriti Nutrients filed with exchangesboard shareholder meetingslow——
31 Aug 2026 · NSE seeks clarification from Kriti Nutrients on Q1 FY27 resultscompliancelow——
14 Aug 2026 · 30th AGM outcomes: dividend confirmed, MD and JMD reappointedboard shareholder meetingslow——
14 Aug 2026 · 30th AGM results: All 8 resolutions passed, 300% dividend confirmedcomplianceminimal——
13 Aug 2026 · Kriti Nutrients publishes Q1 FY27 results in newspaperscomplianceminimal——
12 Aug 2026 · Kriti Nutrients 30th AGM proceedings; key resolutions on dividend, director re-appointmentsboard shareholder meetingsmedium——
11 Aug 2026 · Q1 FY27 Results: Revenue up 7.9%, PAT marginally lower at Rs 9.06 crresultshigh——
11 Aug 2026 · Kriti Nutrients Q1 FY27 results: revenue up 7.9%, PAT dips slightlyresultshigh——
Source: exchange announcements; reaction = close-to-close from the filing's session.

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in